|
Nathaniel "Ned" David, PhD, a co-founder of Kythera, and Chief Science Officer, looks for unexpected ways to take science and marry it with the unmet needs in aesthetic medicine. As the co-founder of Syrrx (acquired by Takeda for $270 million in 2005) and Achaogen, he has experience creating and growing innovative biotechnology companies. Ned was named one of the Top 100 innovators in the world under 35 (2002) by the MIT Technology Review. Ned holds numerous pending and issued patents in fields such as nanovolume crystallography, antibiotic resistance, and aesthetic medicine. He sits on the executive board of the College of Letters and Sciences, University of California, Berkeley (UC Berkeley) and is a member of the board of trustees of the UC Foundation. He holds a PhD from UC Berkeley in Molecular and Cellular Biology and an AB in Biology from Harvard College. | 